USV Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: USV Private Limited Pharmaceutical Export Portfolio Dataset — 5 Products, $21.8M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

USV Private Limited — Pharmaceutical Exporter Profile (2026) | 5 Products, $21.8M Trade | TransData Nexus

Product Portfolio — Top 5 by Export Value

USV Private Limited exports 5 pharmaceutical products across 5 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Metformin	Diabetes & Endocrine	$9.2M	240	2.0%	10
2	Doxycycline	Antibiotics	$6.3M	126	5.3%	2
3	Ras	Ayurvedic & Herbal Products	$4.9M	98	1.6%	8
4	Repaglinide	Advanced Diabetes Medications	$883.7K	46	12.8%	3
5	Griseofulvin	Advanced Antifungals	$500.0K	10	1.4%	5

USV Private Limited exports 5 pharmaceutical products across 5 therapeutic categories with a total export value of $21.8M. The top category is Diabetes & Endocrine (42.2% of portfolio), followed by Antibiotics (28.9%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

USV Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

USV Private Limited, established on August 25, 1961, is a prominent Indian pharmaceutical and biotechnology company headquartered in Mumbai, Maharashtra. Founded by Vithal Balkrishna Gandhi, the company has evolved into a leading producer of Metformin in India and operates across 75 countries globally.

The company is privately held, with authorized capital of ₹1,250 crore and paid-up capital of ₹915.91 crore. As of March 2026, USV Private Limited employs approximately 5,000 individuals. The company's official website is www.usvindia.com.

2Manufacturing Facilities

USV Private Limited operates seven manufacturing plants across India, including four dedicated to formulations, two for Active Pharmaceutical Ingredients (APIs), and one for biological drugs. These facilities adhere to current Good Manufacturing Practice (cGMP) standards, ensuring the production of high-quality pharmaceutical products. The company's manufacturing capabilities encompass oral solids, injectables (pre-filled syringes and vials), ophthalmics, biosimilars, and peptides.

3Key Leadership

The leadership team at USV Private Limited includes:

Leena Tewari: Chairperson
Prashant Tewari: Managing Director
Jayant Dwivedy: Chief Operating Officer and Executive Director
Deepak Keshav Ghaisas: Director
Murugappan Muthiah Venkatachalam: Director
Vilas Gandhi Tewari: Director
Debabrata Bhadury: Director
Aneesha Gandhi Tewari: Director

This team drives the company's strategic direction and operational excellence.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does USV Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

USV Private Limited has a significant presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has obtained over 100 product approvals worldwide and filed more than 30 Drug Master Files (DMFs) globally. This extensive regulatory compliance underscores USV's commitment to meeting international standards and facilitating market access in these regions.

2Emerging Markets

In emerging markets across Africa, Latin America, and Southeast Asia, USV Private Limited leverages its World Health Organization (WHO) prequalification to enhance access to essential medicines. This strategic approach enables the company to expand its footprint and address healthcare needs in these regions effectively.

3Geographic Strategy

USV Private Limited's geographic strategy demonstrates a balanced diversification across various therapeutic categories and global markets. The company's export portfolio spans five therapeutic areas, with a concentration in diabetes and endocrine disorders, antibiotics, and Ayurvedic and herbal products. This diversification mitigates concentration risk and positions USV to capitalize on growth opportunities across different regions and therapeutic segments.

USV Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

USV Private Limited maintains active registrations with the U.S. Food and Drug Administration (FDA) for its manufacturing facilities. The company has received approvals for Abbreviated New Drug Applications (ANDAs) and has filed multiple Drug Master Files (DMFs), reflecting its commitment to meeting FDA standards. Inspection histories indicate compliance with FDA regulations, further affirming the company's dedication to quality and safety in its products.

2WHO & EU GMP

The company's manufacturing facilities are certified by the World Health Organization (WHO) and hold European Union Good Manufacturing Practice (EU GMP) certificates. These certifications validate USV Private Limited's adherence to international quality standards, ensuring the safety and efficacy of its pharmaceutical products in global markets.

3CDSCO & Indian Regulatory

USV Private Limited holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO) and has obtained approvals from state drug controllers across India. The company also possesses export No Objection Certificates (NOCs), facilitating its international trade and compliance with Indian regulatory requirements.

USV Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the pharmaceutical industry, USV Private Limited faces competition from both domestic and international companies. Key competitors include multinational corporations and other Indian pharmaceutical firms operating in similar therapeutic segments. Market share comparisons indicate that USV holds a significant position in the Indian market, particularly in the oral anti-diabetic and cardiac segments. The company's focus on quality, regulatory compliance, and diverse product offerings contributes to its competitive edge.

2Key Differentiators

USV Private Limited's key differentiators include its strong presence in the diabetes and cardiology segments, extensive regulatory approvals across multiple countries, and a diversified product portfolio encompassing oral solids, injectables, ophthalmics, biosimilars, and peptides. These strengths enable the company to meet a wide range of patient needs and maintain a competitive position in the global pharmaceutical market.

3Strategic Position

USV Private Limited's current strategic direction focuses on expanding its generics and specialty products portfolio, with an emphasis on biosimilars and contract development and manufacturing organization (CDMO) services. The company's future outlook includes leveraging its R&D capabilities and global manufacturing footprint to drive growth and innovation in the pharmaceutical industry.

Buyer Due Diligence Brief — Evaluating USV Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

USV Private Limited has a robust track record in pharmaceutical manufacturing, with consistent export volumes and a diverse product range. The company's adherence to international quality standards, as evidenced by its certifications and regulatory approvals, underscores its reliability as a supplier. Ongoing monitoring of regulatory compliance and market performance is recommended to ensure sustained reliability.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Registration: Confirm active registrations and approved ANDAs through the FDA's official database.
WHO-GMP Certification: Obtain copies of WHO-GMP certificates from USV Private Limited.
EU GMP Certification: Request EU GMP certificates from the company.

Frequently Asked Questions — USV Private Limited

How many pharmaceutical products does USV Private Limited export from India?

USV Private Limited exports 5 pharmaceutical products across 5 therapeutic categories. The top exports are Metformin ($9.2M), Doxycycline ($6.3M), Ras ($4.9M), Repaglinide ($883.7K), Griseofulvin ($500.0K). Total export value is $21.8M.

What is USV Private Limited's total pharmaceutical export value?

USV Private Limited's total pharmaceutical export value is $21.8M, based on 520 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does USV Private Limited cover?

USV Private Limited exports across 5 therapeutic categories. The largest are Diabetes & Endocrine (42.2%, 1 products), Antibiotics (28.9%, 1 products), Ayurvedic & Herbal Products (22.5%, 1 products).

Get Full USV Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.

USV Private Limited

USV Private Limited — Export Portfolio & Destination Treemap

Who is USV Private Limited? — Company Overview & Market Position

What Does USV Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

USV Private Limited Therapeutic Categories — 5 Specializations